Revenue increased 9% to $54.9 billion GAAP1 operating earnings were$367 million; GAAP diluted EPS was $1.05 Non-GAAP operating earnings increased 10$666 million; non-GAAP diluted EPS increased 20% to $2.08 Fiscal year 2024 non-GAAP EPS guidance2 raised and narrowed to$7.30 to $7.40, from$7.20 to $7.35 Company provides preliminary fiscal year 2025 non-GAAP EPS guidance of at least$7.50 DUBLIN, Ohio, May 2, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2024 ...